Sarcopenia in cirrhotic patients: Does frailty matter while waiting for a liver transplant?  

作　　者：Xing-Jie Li Kang He 

机构地区：[1]Division of Transplant Surgery,Mayo Clinic Arizona,Phoenix,AZ 85054,United States [2]Department of Liver Surgery,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China

出　　处：《World Journal of Gastrointestinal Surgery》2024年第1期257-259,共3页世界胃肠外科杂志（英文版）（电子版）

摘　　要：Sarcopenia reflects patient frailty and should be routinely assessed due to its high prevalence in cirrhotic patients awaiting liver transplants.Pre-transplant nutritional optimization should be tailored for patients with a definitive diagnosis of sarcopenia,therefore improving functional status at transplant and reducing posttransplant mortality.Hepatologists and transplant surgeons should have raised awareness regarding sarcopenia and the reflected frailty that hinder posttransplant outcomes.The policymakers should also take into account when modifying the organ allocation model that sarcopenia or frailty might become a decisive factor in allocating organs for cirrhotic patients,in order to ensure post-transplant survival and quality of life.

关 键 词：SARCOPENIA Liver transplant Organ allocation policy CIRRHOSIS FRAILTY 

分 类 号：R575.2[医药卫生—消化系统]